Departamento de Biotecnología Microbiana, Centro Nacional de Biotecnología, Consejo Superior de Investigaciones Científicas (CSIC), Darwin 3, Cantoblanco,Madrid 28049, Spain; and the Unidad de Resistencia a Antibióticos y Virulencia Bacteriana asociada al Consejo Superior de Investigaciones Científicas (CSIC), Madrid, Spain.
Unidad de Resistencia a Antibióticos y Virulencia Bacteriana asociada al Consejo Superior de Investigaciones Científicas (CSIC), Madrid, Spain; and the Departamento de Microbiología, Hospital Universitario Ramón y Cajal, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid 28034, Spain.
Nat Rev Microbiol. 2015 Feb;13(2):116-23. doi: 10.1038/nrmicro3399. Epub 2014 Dec 15.
Metagenomic studies have shown that antibiotic resistance genes are ubiquitous in the environment, which has led to the suggestion that there is a high risk that these genes will spread to bacteria that cause human infections. If this is true, estimating the real risk of dissemination of resistance genes from environmental reservoirs to human pathogens is therefore very difficult. In this Opinion article, we analyse the current definitions of antibiotic resistance and antibiotic resistance genes, and we describe the bottlenecks that affect the transfer of antibiotic resistance genes to human pathogens. We propose rules for estimating the risks associated with genes that are present in environmental resistomes by evaluating the likelihood of their introduction into human pathogens, and the consequences of such events for the treatment of infections.
宏基因组学研究表明,抗生素耐药基因在环境中无处不在,这使得人们认为这些基因有很高的风险传播到导致人类感染的细菌中。如果这是真的,那么估计耐药基因从环境储库传播到人类病原体的实际风险就非常困难。在这篇观点文章中,我们分析了当前抗生素耐药性和抗生素耐药基因的定义,并描述了影响抗生素耐药基因向人类病原体转移的瓶颈。我们提出了通过评估基因进入人类病原体的可能性及其对感染治疗的影响来估计与环境耐药组中存在的基因相关风险的规则。